Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Clinical trial NCT04513028 · RECRUITING
Trial details
- NCT number
- NCT04513028
- Sponsor
- Kelly McMasters
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2026-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.